Cerberus Therapeutics
Boston, US · Founded 2020 · Delaware corporation
Cerberus Therapeutics is a biotechnology company developing therapeutics based on nanobody technology, a tolerance induction platform, and a KappaLink platform. Its work focuses on immune tolerance and antibody-based drug development.
BiotechDeep TechHealthtech
Founders & leadership
Cerberus Therapeutics was founded in 2020 by Novalia Pishesha.
NP
Novalia PisheshaFounder
XS
Xiaohong SangNamed on SEC filing
XJ
Xiaowei JinNamed on SEC filing
HL
Harvey LodishFounder
HP
Hidde PloeghFounder
NP
Novalia Pishesha, PhDCo-founder, BoD, SAB
HL

Hidde L. Ploegh, PhDCo-Founder, SAB
HF

Harvey F. Lodish, PhDCo-Founder, BoD
Reported raises · per SEC filings
Form D private placements$4M disclosed across 1 round · 2021
▶$4MraisedJan 2022 · 1 investors · BiotechnologyRule 506(b)
▶$4MraisedJan 2022 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Xiaohong SangExecutive Officer
- Xiaowei JinDirector
- Harvey LodishDirector
- Novalia PisheshaExecutive Officer, Director
- Offering amount
- $5M
- Amount sold
- $4M
- First sale
- Dec 2021
- Incorporated
- Corporation, Delaware, 2020
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 1
by search overlapCompanies competing with Cerberus Therapeutics for the same Google search keywords, organic and paid, via search-intersection analysis.
Frequently asked questions
- What does Cerberus Therapeutics do?
- Cerberus Therapeutics is a biotechnology company developing therapeutics based on nanobody technology, a tolerance induction platform, and a KappaLink platform. Its work focuses on immune tolerance and antibody-based drug development.
- Who founded Cerberus Therapeutics?
- Cerberus Therapeutics was founded by Novalia Pishesha in 2020.
- How much funding has Cerberus Therapeutics raised?
- Cerberus Therapeutics has disclosed $4M raised across 1 round.
- Where is Cerberus Therapeutics headquartered?
- Cerberus Therapeutics is headquartered in Boston, US.